Role of radiotherapy in the management of brain metastases of NSCLC – Decision criteria in clinical routine

Lung cancer is the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers [1]. 10% of patients with NSCLC have brain metastases at diagnosis, and 25% –40% develop brain metastases during their disease [2]. Approaches in the management of brain metastases include surgery, stereotactic radiosurgery (SRS), fractionated stereotactic radiotherapy, whole brain radiation therapy (WBRT), systemic treatments or best supportive care alone [3].

Source: Radiotherapy and Oncology - November 10, 2020 Category: Radiology Authors: Markus Glatzer, Corinne Faivre-Finn, Dirk De Ruysscher, Joachim Widder, Paul Van Houtte, Esther G.C. Troost, Ben J. Slotman, Sara Ramella, Christoph P öttgen, Stephanie T.H. Peeters, Ursula Nestle, Fiona McDonald, Cecile Le Pechoux, Rafal Dziadziuszko, J Tags: Original Article Source Type: research